Mouse Anti-CDCA8 Recombinant Antibody (CBYY-C1700) (CBMAB-C3138-YY)

Cui, X. H., Peng, Q. J., Li, R. Z., Lyu, X. J., Zhu, C. F., & Qin, X. H. (2021). Cell division cycle associated 8: A novel diagnostic and prognostic biomarker for hepatocellular carcinoma. Journal of Cellular and Molecular Medicine.

Li, W. X., Zhou, R. Q., Liu, Y., & Zhang, G. Y. (2021). Expression and clinical relevance of cell division cycle associated 8 (CDCA8) gene in endometrial cancer patients. European Journal of Gynaecological Oncology, 42(2), 278-285.

Li, B., Liu, B., Zhang, X., Liu, H., & He, L. (2020). KIF18B promotes the proliferation of pancreatic ductal adenocarcinoma via activating the expression of CDCA8. Journal of cellular physiology, 235(5), 4227-4238.

Gao, X., Wen, X., He, H., Zheng, L., Yang, Y., Yang, J., ... & Zhang, S. (2020). Knockdown of CDCA8 inhibits the proliferation and enhances the apoptosis of bladder cancer cells. PeerJ, 8, e9078.

Yu, D., Shi, L., Bu, Y., & Li, W. (2019). Cell division cycle associated 8 is a key regulator of tamoxifen resistance in breast cancer. Journal of breast cancer, 22(2), 237-247.

Ci, C., Tang, B., Lyu, D., Liu, W., Qiang, D., Ji, X., ... & Ding, W. (2019). Overexpression of CDCA8 promotes the malignant progression of cutaneous melanoma and leads to poor prognosis. International journal of molecular medicine, 43(1), 404-412.

Bu, Y., Shi, L., Yu, D., Liang, Z., & Li, W. (2019). CDCA8 is a key mediator of estrogen-stimulated cell proliferation in breast cancer cells. Gene, 703, 1-6.

Bi, Y., Chen, S., Jiang, J., Yao, J., Wang, G., Zhou, Q., & Li, S. (2018). CDCA8 expression and its clinical relevance in patients with bladder cancer. Medicine, 97(34).

Phan, N. N., Wang, C. Y., Li, K. L., Chen, C. F., Chiao, C. C., Yu, H. G., ... & Lin, Y. C. (2018). Distinct expression of CDCA3, CDCA5, and CDCA8 leads to shorter relapse free survival in breast cancer patient. Oncotarget, 9(6), 6977.

Jeon, T. W., Ko, M. J., Seo, Y. R., Baik, I. H., Hwang, I., Ryoo, H. M., ... & Lee, Y. H. (2017). Knockdown of cell division cycle-associated 8 (CDCA8) suppresses hepatocellular carcinoma growth via the upregulation of tumor suppressor ATF3.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols